Home
Suven Pharmaceuticals Ltd Share Price History
Suven Pharmaceuticals Ltd
NSE : 21 Feb, 2025
1226.4515.3 (1.3%)
Prev Close
1211.2
Open Price
1203.9
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
4459981
Today's High / Low
1232.3 / 1175.8
52 WK High / Low
1360.0 / 598.0
Market Price of Suven Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Suven Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2019 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 8.59 |
| YoY Gr. | - |
| Net Profit (Cr.) | 109 |
| BVPS | 0 |
Key Financial Parameters
| Parameter | 2019 |
|---|---|
| Return on Capital Emp. % | 23.66 |
| Op. Profit Mgn % | 45.56 |
| Net Profit Mgn % | 28.92 |
| Debt to Equity % | 0.14 |
Latest Shareholding
Promoters Holdings Over Time
About Suven Pharmaceuticals Ltd
- Suven Pharmaceuticals Limited (SPL) is a bio-pharmaceutical company, incorporated on 6th November, 2018 and is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies. The Company is a CDMO that supports global life sciences industry and fine chemical majors in their NCE development endeavors.
- Its services include custom synthesis, process R&D, scale-up and contract manufacturing of intermediates, APIs and formulations.
- Suven Pharma Inc., a Delaware Company, is a WOS (wholly owned subsidiary) of SPL, is a SPV (Special Purpose Vehicle) created on 9th March 2019, for undertaking various business opportunities in Pharma Industry.
Popular Search
FAQs for Suven Pharmaceuticals Ltd Share Price History
What are the key events that typically impact Suven Pharmaceuticals Ltd's share price history?
Key events that impact Suven Pharmaceuticals Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Suven Pharmaceuticals Ltd's share price history?
Stock splits reduce the nominal price of Suven Pharmaceuticals Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Suven Pharmaceuticals Ltd?
Dividends can influence Suven Pharmaceuticals Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Suven Pharmaceuticals Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Suven Pharmaceuticals Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Suven Pharmaceuticals Ltd’s share price history?
To understand Suven Pharmaceuticals Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
